|
|
Advertisement |
|
|
|
Advertisement |
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
|
|
Advertisement |
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Learn more
|
|
Europe |
 |
Is Patient Engagement Brexit-Ready? |
Whatever the final outcome of Brexit, investing in supporting advocacy communities will be an important element of maintaining trusted relationships with patient groups and stakeholders in the UK and the EU, write Nick Hicks and Tamsin Rose
… /Read more/ |
|
|
|
ADVERTISEMENT
|
|
/ January 22–23, 2019: 14th Biosimilars Summit
/ |
Alexandria, VA |
/ January 23–24, 2019: Data Analytics and Decisions
/ |
Philadelphia, PA |
/ January 24–25, 2019: Specialty Therapies 2019
/ |
Las Vegas, NV |
/ January 29–30, 2019: 6th Annual Clinical Data Disclosure and Transparency
/ |
Philadelphia, PA |
/ February 4–5, 2019: Disease Awareness Campaigns
/ |
Philadelphia, PA |
/ March 4–6, 2019: 20th Annual Patient Assistance and Access Programs – PAP 2019
/ |
Baltimore, MD |
/ March 12–13, 2019: Pharmaceutical Compliance Congress Asia
/ |
Shanghai, China |
|
|
|
Advertisement |
 |
|
|
ADVERTISEMENT
|
|
|
Advertisement |
 |
|
|
Industry update |
//
Acer Therapeutics (Newton, MA) appointed Salma Jutt as Chief Commercial Officer.
//
Bellicum Pharmaceuticals (Houston, TX) announced the appointment of Atabak Mokari as Chief Financial Officer.
//
NeoGenomics (Ft. Myers, FL) announced the appointment of Lawrence M. Weiss, M.D., as Chief Scientific Officer.
//
Matthew Plunkett, Ph.D., joined Nkarta Therapeutics (South San Francisco, CA) as Senior Vice president and Chief Financial Officer.
//
Oncolytics Biotech (Calgary, Alberta and San Diego, CA) appointed Dr. Rita Laeufle, M.D., Ph.D., as Chief Medical Officer.
//
Ziopharm Oncology (Boston, MA) promoted David Mauney, M.D., to President.
|
|
|